Ignite Creation Date:
2025-12-25 @ 1:05 AM
Ignite Modification Date:
2026-03-01 @ 4:45 PM
Study NCT ID:
NCT03059693
Status:
COMPLETED
Last Update Posted:
2017-02-23
First Post:
2017-02-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Tolerability of HAT1 in Patients With Moderate to Severe Atopic Dermatitis
Sponsor:
Haus Bioceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HCTP16MD01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None